March 3 (Reuters) - Orchestra Biomed Holdings Inc OBIO.O:
ORCHESTRA BIOMED ANNOUNCES PRESENTATIONS HIGHLIGHTING AVIM THERAPY POTENTIAL IMPACT ON HYPERTENSIVE HEART DISEASE AND HEART FAILURE AT THT AND CRT
Source text: ID:nGNX7SV91
Further company coverage: OBIO.O
((Reuters.Briefs@thomsonreuters.com;))